193 related articles for article (PubMed ID: 32496920)
1. Construction of immune-related risk signature for uveal melanoma.
Zhang Z; Ni Y; Chen G; Wei Y; Peng M; Zhang S
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):912-919. PubMed ID: 32496920
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis.
Wang J; Liu M; Sun J; Zhang Z
J Cancer Res Clin Oncol; 2024 Jan; 150(1):23. PubMed ID: 38246894
[TBL] [Abstract][Full Text] [Related]
4. Identification of survival-related genes and a novel gene-based prognostic signature involving the tumor microenvironment of uveal melanoma.
Lei S; Zhang Y
Int Immunopharmacol; 2021 Jul; 96():107816. PubMed ID: 34162166
[TBL] [Abstract][Full Text] [Related]
5. Identification of Survival-Related Metabolic Genes and a Novel Gene Signature Predicting the Overall Survival for Patients with Uveal Melanoma.
Guo X; Yu X; Li F; Xia Q; Ren H; Chen Z; Xing Y
Ophthalmic Res; 2022; 65(5):516-528. PubMed ID: 35390784
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a pyroptosis-related gene signature associated with the tumor microenvironment in uveal melanoma.
Zhang F; Deng Y; Wang D; Wang S
Sci Rep; 2022 Jan; 12(1):1640. PubMed ID: 35102195
[TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes.
Zhao H; Chen Y; Shen P; Gong L
Math Biosci Eng; 2021 Sep; 18(6):8045-8063. PubMed ID: 34814288
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis identifies key genes related to metastasis and a robust gene-based prognostic signature in uveal melanoma.
Lei S; Zhang Y
BMC Med Genomics; 2022 Mar; 15(1):61. PubMed ID: 35300699
[TBL] [Abstract][Full Text] [Related]
10. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
Zhao M; Yu Y; Song Z
Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
[TBL] [Abstract][Full Text] [Related]
12. Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma.
Xin X; Zhang Y; Ling F; Wang L; Sheng X; Qin L; Zhao X
Exp Eye Res; 2019 Mar; 180():242-249. PubMed ID: 30615885
[TBL] [Abstract][Full Text] [Related]
13. A Novel Ferroptosis-Associated Gene Signature to Predict Prognosis in Patients with Uveal Melanoma.
Luo H; Ma C
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33540700
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic Analysis Reveals Central Role for Tumor-Infiltrating Immune Cells in Uveal Melanoma Progression.
Lachota M; Lennikov A; Malmberg KJ; Zagozdzon R
J Immunol Res; 2021; 2021():9920234. PubMed ID: 34195299
[TBL] [Abstract][Full Text] [Related]
16. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
Wan Q; Sang X; Jin L; Wang Z
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
[TBL] [Abstract][Full Text] [Related]
17. Integrated analyses identify potential prognostic markers for uveal melanoma.
Ni Y; Zhang Z; Chen G; Long W; Tong L; Zeng J
Exp Eye Res; 2019 Oct; 187():107780. PubMed ID: 31469983
[TBL] [Abstract][Full Text] [Related]
18. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
[TBL] [Abstract][Full Text] [Related]
19. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
20. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
